Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Notice Of Board Meeting For Consideration Of Unaudited Financial Results Of The Company For The Quarter And Six Months Ended 30Th September 2020.

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2020 ,inter alia, to consider and approve Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research Company Limited will be held on Monday, 9th November 2020, inter alia, to consider and take on record, the unaudited financial results of the Company for the quarter and six months ended 30th September 2020. Further, kindly note that pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons, shall remain closed upto 48 hours after the declaration of financial results of the Company on 9th November 2020. This is for your information and record.
30-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Shareholding for the Period Ended September 30, 2020

Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
19-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliance Certificate - Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Pursuant to the requirement of Regulation 7 (3) ofthe SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility were duly maintained by the Company''s Registrar and Share Transfer Agent, viz., link lntime India Private Limited, ( a SEBI registered Category-! Registrar & Share Transfer Agent with Registration Number : INR000004058), as specified under regulation 7(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 during the half year ended 30th September 2020.
16-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Submission Of Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

As per the requirements of Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the Compliance Certificate issued by M/s. Veenit Pal & Associates, Practicing Company Secretaries, for the half year ended 30th September 2020.
16-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement Of Investor Complaints For The Quarter Ended September 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- DEBASHIS DEYDesignation :- Company Secretary and Compliance Officer
14-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Dear Sir/Madam, Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we enclose herewith the Press Release titled 'SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of SDN-037 for the Treatment of Inflammation and Pain Associated with Ocular Surgery - Met Pre-specified Primary and Secondary Endpoints' - being released by the Company, which is self-explanatory. We request you to kindly take the same on record.
14-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Clarification: Voting Results Of Fifteenth Annual General Meeting Of The Company Held On 30Th September, 2020

It has come to our notice that the 'Total Number of Share Holders on Record Date' disclosed in our aforesaid letter is mentioned as 96117 instead of correct number 96177. We are therefore re-submitting the Voting Results with the correct 'Total Number of shareholders for your ready reference. Kindly note that there are no other changes / modifications in the voting results submitted by the Company with the exchanges earlier.
06-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Sun Pharma Advanced Research Company Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
03-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Increase In Authorized Share Capital Of The Company

In compliance with the provisions of regulation 30 read with Para A of Part A of schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the shareholders of the company at their 15th Annual General Meeting held on Wednesday, 30th September 2020 have approved increase in Authorised Share Capital of the Company from the present Rs. 32,50,00,000/- divided into 32,50,00,000 Equity Shares of Re. 1/- each to Rs. 37,50,00,000/- divided into 37,50,00,000 Equity Shares of Re. 1/- each.
02-10-2020
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

In compliance with the provisions of regulation 30 read with Para A of Part A of schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the shareholders of the company at their 15th Annual General Meeting held on Wednesday, 30th September 2020 have approved Shifting of Registered office of the Company from current location to: Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli - Vadodara Highway, Manjusar - 391 775 District Vadodara Gujarat, India You are requested to kindly take the same on record.
02-10-2020
Next Page
Close

Let's Open Free Demat Account